UNSPSC 51171819: Thiethylperazine

This classification denotes an antiemetic agent with the molecular formula C22H29N3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8ETK1WAF6R, chemically known as 10h-phenothiazine, 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)- but generally known as thiethylperazine, which bears US NIH Compound Identifier 5440. European Medicines Agency schedules Thiethylperazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10973MIG.

UNSPSC 51171819 Thiethylperazine is a Commodity code that maps poorly to current state and local procurement activity. The code nominally denotes a specific pharmaceutical compound, but recent opportunities tagged under it show little transactional alignment with that scope. Collin County Community Supervision and Corrections Department issued RFP 2026-327 for offender specimen collection and drug testing services (due July 23, 2026), a scope covering lab operations, immunoassay screening, confirmation testing, and alternative testing methodologies — none of which involve procurement of thiethylperazine as an input. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to explore direct-to-manufacturer prescription programs with pharmacy benefit managers, a market-intelligence exercise focused on contracting strategy rather than individual pharmaceutical procurement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon, requiring manufacturers to supply comprehensive product lines through authorized wholesalers — a broad-based pharmaceutical supply contract unrelated to thiethylperazine specifically. The issuing bodies span county corrections departments, state health agencies, and multistate cooperative purchasing alliances, but none of the recent opportunities explicitly solicit thiethylperazine.

Recent activity appears concentrated in Texas and the upper Midwest, but the code shows little meaningful procurement signal for the specific compound it names. The Collin County RFP (estimated contract value $600,000 over two years with optional renewals through 2031) targets drug-testing lab services, not pharmaceutical supplies. The MMCAP RFP addresses generic pharmaceuticals broadly, with pricing weighted at 75 percent and contract commencement July 1, 2026, but does not list thiethylperazine among the deliverables. The Texas HHS RFI is exploratory and does not commit to specific drug classes or purchase volumes. No evidence in the source supports active state or local procurement of thiethylperazine as a standalone commodity under this code in the current cycle.